The buttocks are not an FDA-approved injection site for semaglutide
1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss
Hypersensitivity reactions may manifest in various ways, ranging from local injection site reactions such as erythema, swelling, and pruritus to more severe systemic reactions including angioedema, anaphylaxis, or generalized urticaria
SSRIs and SNRIs , the most commonly prescribed antidepressants in the UK, generally have a neutral or potentially beneficial effect on glycaemic control in some individuals
Unlike SGLT2 inhibitors (another class of diabetes medications), semaglutide does not have diuretic properties that would directly increase urine output